Post Profile






Related Posts


FDA lifts hold on AstraZeneca head and neck cancer trials

Health : Reuters: Health

LONDON (Reuters) - U.S. officials have given a green light for two clinical trials testing AstraZeneca's cancer immunotherapy drug durvalumab in head and neck cancer to resume recruiting patients, lifting a hold imposed following ca...

New Ovarian Cancer Treatment Approved In US

US Politics / Liberal : Alan Colmes' Liberaland

(Reuters) – AstraZeneca Plc’s ovarian cancer drug has been granted an accelerated approval by the U.S. health regulator, a day after the treatment was approved by the European Commission. An advisory panel to the U.S. Food and Drug ...

AstraZeneca pulls cancer drug application in Europe

Health : Reuters: Health

LONDON (Reuters) - AstraZeneca has pulled an application seeking European approval to sell its experimental cancer drug cediranib in combination with chemotherapy to treat ovarian cancer because of late-stage questions raised by reg...

AstraZeneca ovarian cancer drug slows disease markedly in study

Health : Reuters: Health

LONDON (Reuters) - AstraZeneca's ovarian cancer drug Lynparza slowed disease progression sharply in a closely watched clinical trial, boosting hopes for a product that belongs to a novel drug class called PARP inhibitors.

FDA expands use of AstraZeneca/Merck ovarian cancer drug

Health : Reuters: Health

(Reuters) - The U.S. Food and Drug Administration on Thursday expanded the use of Lynparza, sold by AstraZeneca Plc and Merck & Co Inc, to include ongoing treatment of patients with recurrent ovarian cancer who have responded to pla...

Comments


Copyright © 2016 Regator, LLC